Rapid Enhancement of Beta 2-interferon/B-cell Differentiation Factor BSF-2 Gene Expression in Human Fibroblasts by Diacylglycerols and the Calcium Ionophore A23187
Overview
Authors
Affiliations
The expression in human fibroblasts of the beta 2-interferon (IFN-beta 2) gene, which is now recognized to be identical to the gene encoding B-cell differentiation factor BSF-2, is enhanced by several cytokines that affect cell growth (tumor necrosis factor, interleukin 1, platelet-derived growth factor, and beta 1-interferon). We have examined the possibility that IFN-beta 2 gene expression is regulated through activation, by diacylglycerol, of the protein kinase C pathway. The synthetic diacylglycerols 1,2-dioctanoylglycerol (diC8) and 1-oleoyl-2-acetylglycerol strongly enhanced IFN-beta 2, but not IFN-beta 1, gene expression in human fibroblasts (FS-4 strain). An increase in IFN-beta 2 mRNA level was detected within 15 min after addition of diC8 (290 microM) to FS-4 cells and was maximal approximately 20 hr later. An increase in IFN-beta 2 gene transcription was detected within 5 min of addition of diC8, and the rate of transcription was near-maximal by 15-30 min. The enhancement of IFN-beta 2 gene expression by diC8, interleukin 1, or tumor necrosis factor was not prevented by H8, a preferential inhibitor of cAMP- and cGMP-dependent protein kinases, but was blocked by H7, an inhibitor of protein kinase C as well as of cyclic nucleotide-dependent protein kinases. diC8 was found to protect FS-4 cells from the cytopathic effect of vesicular stomatitis virus; this protection was blocked by polyclonal or monoclonal antibodies that neutralize IFN-beta, suggesting that the antiviral effect was due to the secretion of IFN-beta 2 by the diC8-treated fibroblasts. The calcium ionophore A23187 (1-10 microM) also elicited an increase in the level of IFN-beta 2 mRNA in FS-4 fibroblasts; appropriate combinations of A23187 and diC8 had at least an additive effect in enhancing IFN-beta 2 mRNA levels. These results show that protein kinase C-activating or [Ca2+]-elevating agents rapidly increase the expression of the IFN-beta 2 gene in human fibroblasts.
Aziz J, Abu Kassim N, Abu Kasim N, Haque N, Rahman M BMC Complement Altern Med. 2015; 15:215.
PMID: 26152209 PMC: 4495848. DOI: 10.1186/s12906-015-0749-6.
The paradigm of IL-6: from basic science to medicine.
Naka T, Nishimoto N, Kishimoto T Arthritis Res. 2002; 4 Suppl 3:S233-42.
PMID: 12110143 PMC: 3240141. DOI: 10.1186/ar565.
Barkhudaryan N, Dunn A Neurochem Res. 1999; 24(9):1169-80.
PMID: 10485589 DOI: 10.1023/a:1020720722209.
Ahn M, Siziopikou K, Plate J, Casey L, Silver M, Harris J Cancer Immunol Immunother. 1997; 45(1):37-44.
PMID: 9353425 PMC: 11037664. DOI: 10.1007/s002620050398.
Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?.
Biffl W, Moore E, Moore F, Peterson V Ann Surg. 1996; 224(5):647-64.
PMID: 8916880 PMC: 1235442. DOI: 10.1097/00000658-199611000-00009.